New Zealand markets closed

MedinCell S.A. (MEDCL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
13.26-0.14 (-1.04%)
At close: 05:35PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 389.77M
Enterprise value 420.85M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)43.13
Price/book (mrq)N/A
Enterprise value/revenue 46.60
Enterprise value/EBITDA -11.82

Trading information

Stock price history

Beta (5Y monthly) 1.10
52-week change 3104.58%
S&P500 52-week change 323.20%
52-week high 317.50
52-week low 35.25
50-day moving average 314.18
200-day moving average 39.21

Share statistics

Avg vol (3-month) 3124.01k
Avg vol (10-day) 399.64k
Shares outstanding 529.09M
Implied shares outstanding 629.35M
Float 8N/A
% held by insiders 150.43%
% held by institutions 129.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -209.61%
Operating margin (ttm)-318.27%

Management effectiveness

Return on assets (ttm)-39.49%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)11.95M
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)-36.70%
Gross profit (ttm)N/A
EBITDA -19.97M
Net income avi to common (ttm)-25.04M
Diluted EPS (ttm)-0.86
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.46M
Total cash per share (mrq)N/A
Total debt (mrq)56.06M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.65
Book value per share (mrq)-0.90

Cash flow statement

Operating cash flow (ttm)-11.92M
Levered free cash flow (ttm)-14.5M